Avid Bioservices Profit Margin 2006-2021 | CDMO
Current and historical gross margin, operating margin and net profit margin for Avid Bioservices (CDMO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Avid Bioservices net profit margin as of July 31, 2021 is 12.63%.
|Avid Bioservices Annual Profit Margins
|Avid Bioservices Quarterly Profit Margins
||Medical - Biomedical and Genetics
Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. It also offer process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. Avid Bioservices Inc., formerly known as Peregrine Pharmaceuticals Inc., is based in TUSTIN, United States.